Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma

Figure 2

LUZP2 expression profile at the mRNA level by clinical characteristics in TCGA and validation cohort. (a) Grade in TCGA. (b) Histology in TCGA. (c) IDH1 mutant status in TCGA. (d) Grade in CGGA. (e) Histology in CGGA part B. (f) IDH1 mutant status in CGGA part B. (g) 1p19q codeletion in CGGA part B. (h) Tissue type in CGGA part B. (i) Grade in CGGA part C. (j) Histology in CGGA part C. (k) IDH1 mutant status in CGGA part C. (l) Tissue type in CGGA part C.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)